M
Magnus Medical
A privately held medical device company developing a novel, rapid-acting brain stimulation technology designed to treat people suffering from major depressive disorder (MDD) who have not responded to…
About Magnus Medical
Magnus Medical is a pioneering startup operating in the healthcare sector, specifically focusing on mental health. The company has developed a revolutionary product, the SAINT Neuromodulation System, which aims to treat depression by restoring healthy neural activity in the brain. This is achieved by identifying changes in brain networks, which are believed to be the cause of depression, and using personalized targeting to treat these underlying causes.
The company's primary market is individuals suffering from treatment-resistant depression, a condition that traditional methods have failed to alleviate. The SAINT Neuromodulation System has received clearance from the FDA, marking a significant milestone in Magnus Medical's journey to improve mental health treatment.
Magnus Medical's business model revolves around the SAINT Neuromodulation System. The company generates revenue by selling this system to healthcare providers, who then use it to treat patients suffering from depression. The system uses advanced algorithms and neuroimaging to identify the optimal target in the brain for treatment, and then applies precise patterns of stimulation to restore healthy neural activity.
This innovative approach to treating depression has the potential to be a game-changer in the mental health sector. The company is at the forefront of a significant improvement in the care of treatment-resistant depression, and is committed to improving the quality of life for individuals suffering from this condition.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2020
- Headquarters
- Burlingame, United States
- Employees
- 80
- Open positions
- None listed
- Dealroom signal
- 90.1/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Neurology, Mental Health, Neuromodulation and Neurostimulation, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Oct 2021 | $25M | $100M | Red Tree Venture Capital · JAZZ Venture Partners | — |
Growth signals
Latest recorded traffic for Magnus Medical is 3.6K monthly website visits, down 74.3% over the last three months. Magnus Medical's team grew 9.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Red Tree Venture Capital- JPJAZZ Venture Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Magnus Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Magnus Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.